Prostate Cancer Converts Immune Cells into Allies of Tumor

Scientists have discovered that certain macrophages in prostate cancer are reprogrammed to support tumor growth and suppress immune responses. Targeting these cells, specifically the SPP1 protein, in mice improved the effectiveness of immunotherapy, offering a potential new approach for treating advanced prostate cancer.